Goldman Sachs Group Inc. Reduces Position in U.S. Physical Therapy, Inc. $USPH

Goldman Sachs Group Inc. decreased its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 21.9% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 64,411 shares of the company’s stock after selling 18,112 shares during the period. Goldman Sachs Group Inc. owned 0.42% of U.S. Physical Therapy worth $4,661,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Mitsubishi UFJ Asset Management Co. Ltd. increased its position in U.S. Physical Therapy by 952.4% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 442 shares of the company’s stock worth $32,000 after buying an additional 400 shares in the last quarter. Fifth Third Bancorp grew its position in shares of U.S. Physical Therapy by 34.6% in the first quarter. Fifth Third Bancorp now owns 1,030 shares of the company’s stock valued at $75,000 after purchasing an additional 265 shares during the period. Lazard Asset Management LLC purchased a new stake in shares of U.S. Physical Therapy in the fourth quarter valued at $84,000. AlphaQuest LLC purchased a new stake in shares of U.S. Physical Therapy in the first quarter valued at $92,000. Finally, First Horizon Advisors Inc. grew its position in shares of U.S. Physical Therapy by 35.0% in the first quarter. First Horizon Advisors Inc. now owns 1,929 shares of the company’s stock valued at $140,000 after purchasing an additional 500 shares during the period.

Insiders Place Their Bets

In related news, CFO Carey P. Hendrickson sold 698 shares of the business’s stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $86.11, for a total value of $60,104.78. Following the transaction, the chief financial officer owned 27,808 shares in the company, valued at approximately $2,394,546.88. The trade was a 2.45% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, COO Graham D. Reeve sold 1,792 shares of the business’s stock in a transaction dated Monday, August 11th. The stock was sold at an average price of $86.57, for a total value of $155,133.44. Following the completion of the transaction, the chief operating officer owned 22,246 shares in the company, valued at approximately $1,925,836.22. This trade represents a 7.45% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 6,853 shares of company stock valued at $581,406. Insiders own 2.00% of the company’s stock.

Analyst Ratings Changes

USPH has been the subject of a number of recent analyst reports. Wall Street Zen raised U.S. Physical Therapy from a “hold” rating to a “buy” rating in a research report on Saturday. Zacks Research raised U.S. Physical Therapy to a “hold” rating in a research report on Friday, August 8th. Finally, Barrington Research lifted their price objective on U.S. Physical Therapy from $98.00 to $103.00 and gave the company an “outperform” rating in a research report on Friday, August 8th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $110.25.

U.S. Physical Therapy Trading Down 1.3%

NYSE:USPH opened at $78.30 on Wednesday. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.18 and a current ratio of 1.18. U.S. Physical Therapy, Inc. has a one year low of $62.77 and a one year high of $101.19. The business’s 50-day simple moving average is $80.01 and its 200 day simple moving average is $76.46. The stock has a market cap of $1.19 billion, a price-to-earnings ratio of 34.19, a price-to-earnings-growth ratio of 3.97 and a beta of 1.47.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Wednesday, August 6th. The company reported $0.81 EPS for the quarter, topping the consensus estimate of $0.71 by $0.10. U.S. Physical Therapy had a return on equity of 8.78% and a net margin of 5.05%.The business had revenue of $197.34 million for the quarter, compared to analysts’ expectations of $190.24 million. During the same quarter in the previous year, the firm posted $0.73 earnings per share. The company’s revenue was up 18.0% compared to the same quarter last year. As a group, sell-side analysts predict that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, September 12th. Investors of record on Friday, August 22nd were paid a $0.45 dividend. The ex-dividend date was Friday, August 22nd. This represents a $1.80 annualized dividend and a dividend yield of 2.3%. U.S. Physical Therapy’s payout ratio is 78.60%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.